Awakn Life Sciences Announces Closing Of Second Tranche And Upsizing Of Previous Private Placement
Portfolio Pulse from Lara Goldstein
Awakn Life Sciences Corp. (OTCQB:AWKNF) has closed the second tranche of its non-brokered private placement and upsized the original financing option to $4 million. The company is focusing on the R&D of novel therapeutics and IP licensing for addiction treatments, particularly Alcohol Use Disorder.
June 16, 2023 | 12:17 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Awakn Life Sciences has closed the second tranche of its private placement and upsized the financing option to $4 million, focusing on addiction treatment R&D.
The closing of the second tranche and upsizing of the financing option to $4 million demonstrates Awakn Life Sciences' commitment to its R&D efforts in addiction treatments. This could potentially attract more investors and increase the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100